ALPHACENTRIC ADVISORS LLC
Q4 2022 Form 13-F

SAN JUAN, PUERTO RICO
CIK 0001913464 · CRD 170679 · SEC-registered investment adviser
$101.2M Reported Value Total

ALPHACENTRIC ADVISORS LLC reports 8 total accounts under management (AUM). There are 8 discretionary accounts valued at $1,077,282,871, and 0 non-discretionary accounts.

Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
SEC Registered Discretionary Manager
Source: Form ADV filed 2026-06-02
Reported value
$101.2M
Quarter over quarter
+11.4%
Holdings
165
Top-10 concentration
22.1%

Key People

Form ADV owners & control persons
David Scott Miller
MEMBER
Jerry John Szilagyi
MANAGING MEMBER
Michael Thomas Schoonover
MEMBER

Filing Navigation

13F Metrics

Loading 13F Metrics

Q4 2022 13F record

Q4 2022 13F filing summary

Q4 2022 Form 13F portfolio summary
Period of report December 31, 2022
Filed February 07, 2023
Form 13F-HR
Reported value $101.2M
Positions 165
Change in reported value +3.9%
New positions 42
Exited positions 61
Position turnover 45.6%
Top-10 concentration 22.1%

13F filings by quarter

Form 13F filings by quarter
Quarter Positions Value
Q3 2026 13F
Filed Nov 3, 2026
245 $112.6M
Q2 2026 13F
Filed Jul 24, 2026
259 $118.0M
Q1 2026 13F
Filed May 7, 2026
252 $100.1M
Q4 2025 13F
Filed Feb 12, 2026
249 $100.3M
Q4 2024 13F
Filed Jan 31, 2025
209 $100.2M
Q3 2024 13F
Filed Oct 30, 2024
230 $134.5M
Q2 2024 13F
Filed Jul 25, 2024
217 $135.8M
Q1 2024 13F
Filed Apr 24, 2024
228 $165.8M
Q4 2023 13F
Filed Feb 14, 2024
216 $149.0M
Q3 2023 13F
Filed Nov 13, 2023
234 $176.3M
Q2 2023 13F
Filed Aug 8, 2023
231 $180.2M
Q1 2023 13F
Filed May 12, 2023
209 $144.9M
Q4 2022 13F
Filed Feb 7, 2023
165 $101.2M
Q3 2022 13F
Filed Nov 8, 2022
184 $97.4M
Q4 2021 13F
Filed Feb 25, 2022
220 $343.1M

6 earlier quarters on file — choose one from the quarter menu above.

Top 20 holdings · Q4 2022

Largest Q4 2022 13F positions by reported value
# Holding Reported value % of portfolio
1 RITM NEW RESIDENTIAL INVT CORP $4.0M 3.97%
2 HZNP HORIZON THERAPEUTICS PUB L $2.9M 2.87%
3 COOP MR COOPER GROUP INC $2.3M 2.25%
4 GSK GSK PLC $2.1M 2.12%
5 PRCT PROCEPT BIOROBOTICS CORP $2.1M 2.05%
6 EFC ELLINGTON FINANCIAL INC $2.0M 2.02%
7 LKFT GALAPAGOS NV $1.9M 1.86%
8 PFSI PENNYMAC FINL SVCS INC NEW $1.8M 1.74%
9 TSVT 2SEVENTY BIO INC $1.7M 1.67%
10 MFA MFA FINL INC $1.6M 1.54%
11 ADAM NEW YORK MTG TR INC $1.5M 1.51%
12 AUPH AURINIA PHARMACEUTICALS INC $1.5M 1.5%
13 CHRS COHERUS BIOSCIENCES INC $1.5M 1.47%
14 VRNA VERONA PHARMA PLC $1.4M 1.42%
15 BCRX BIOCRYST PHARMACEUTICALS INC $1.4M 1.42%
16 BIO BIO RAD LABS INC $1.4M 1.41%
17 AIRS AIRSCULPT TECHNOLOGIES INC $1.3M 1.32%
18 ISRG INTUITIVE SURGICAL INC $1.3M 1.31%
19 ALNT ALLIED MOTION TECHNOLOGIES I $1.3M 1.29%
20 AVAV AEROVIRONMENT INC $1.3M 1.27%

Values as reported on the Q4 2022 Form 13F. Every position is in the holdings table below.

Filing Details

Loading Activities
Loading Sector Allocation
Crunching numbers

Performance

Loading Performance

Potential New Buys

Finding Potential New Buys

Holdings

Building table
Loading SEC filing data
Loading Form 4 Filings

Beneficial Ownership (Schedule 13D/13G)

Loading 13D/G filings